Cite
Characterization of QuantiFERON-TB-Plus results in latent tuberculosis infected patients with or without immune-mediated inflammatory diseases.
MLA
Chiacchio, Teresa, et al. “Characterization of QuantiFERON-TB-Plus Results in Latent Tuberculosis Infected Patients with or without Immune-Mediated Inflammatory Diseases.” Journal of Infection, vol. 79, no. 1, July 2019, pp. 15–23. EBSCOhost, https://doi.org/10.1016/j.jinf.2019.04.010.
APA
Chiacchio, T., Petruccioli, E., Vanini, V., Cuzzi, G., Massafra, U., Baldi, G., Navarra, A., Scrivo, R., Mastroianni, C., Sauzullo, I., Esposito, C., Palmieri, F., Cantini, F., & Goletti, D. (2019). Characterization of QuantiFERON-TB-Plus results in latent tuberculosis infected patients with or without immune-mediated inflammatory diseases. Journal of Infection, 79(1), 15–23. https://doi.org/10.1016/j.jinf.2019.04.010
Chicago
Chiacchio, Teresa, Elisa Petruccioli, Valentina Vanini, Gilda Cuzzi, Umberto Massafra, Gianpiero Baldi, Assunta Navarra, et al. 2019. “Characterization of QuantiFERON-TB-Plus Results in Latent Tuberculosis Infected Patients with or without Immune-Mediated Inflammatory Diseases.” Journal of Infection 79 (1): 15–23. doi:10.1016/j.jinf.2019.04.010.